EYPT
EYPT
NASDAQ · Pharmaceuticals

Eyepoint Inc

$3.85
-0.14 (-3.51%)
As of Sep 20, 10:15 PM ET ·
Analyst Consensus
Buy
19
Analysts
High
Coverage
Buy 13 68%
Hold 6 32%
Sell 0 0%
Price Target
Analyst Price Target +139.2% upside
Low Target $6.71
Average Target $9.21
High Target $14.14
Current Price $3.85
Current
$3.85
Target
$9.21
$6.71 $9.21 avg $14.14
Scenario Analysis
Bear Case
$6.71
74.3%
Low target
Base Case
$9.21
+139.2%
Avg target
Bull Case
$14.14
+267.3%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$19.11
-79.9% from high
52-Week Low
$3.42
+12.7% from low
Target vs 52W High
$9.21
-51.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%